文献速递类风湿关节炎

类风湿关节炎患者心肌梗死后长期预后不良:全国性病例对照注册研究

Patients with rheumatoid arthritis have impaired long-term outcomes after myocardial infarction: a nationwide case-control registry study.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该研究基于芬兰全国多中心注册数据,回顾性比较1614例合并RA的MI患者与8070例倾向评分匹配的无RA的MI患者,中位随访7.3年。结果显示RA与MI后14年死亡率、再发MI和血运重建风险升高独立相关,RA病程和糖皮质激素使用及剂量是死亡独立预测因素。

要点

  • RA病程和MI前糖皮质激素使用及剂量与死亡独立相关,甲氨蝶呤使用与较低卒中率相关。

核心结论

  • RA是MI后预后不良的独立相关因素,RA病程和糖皮质激素使用及剂量是RA患者MI后死亡的独立预测因素。

研究设计与样本

  • 芬兰全国多中心回顾性队列注册研究,纳入全部合并RA的MI患者1614例(平均年龄74岁),与倾向评分1:5匹配的无RA的MI患者8070例比较,中位随访7.3年。

主要发现

  • MI后累积卒中率在RA与非RA患者间无差异(P=0.322)。
  • RA病程和MI前糖皮质激素使用与较高死亡率(P<0.001)和新发MI(P=0.009)独立相关;MI前较高糖皮质激素剂量与较高长期死亡率独立相关(P=0.002);甲氨蝶呤使用与较低卒中率相关(P=0.034)。
  • 甲氨蝶呤或生物制剂抗风湿药使用与死亡率和新发MI无独立关联;RA血清学状态与结局无关。

临床怎么用

  • 对合并RA的MI患者应加强长期随访和二级预防,关注再发MI和血运重建风险。
  • 评估RA病程及MI前糖皮质激素使用和剂量,以识别MI后死亡高危患者。

局限性

  • 回顾性观察性设计,可能存在残余混杂。
  • 未报告原文中关于其他潜在局限性的信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the long-term outcomes of patients with RA after myocardial infarction (MI). METHODS: All-comer, real-life MI patients with RA (n = 1614, mean age 74 years) were retrospectively compared with propensity score (1:5) matched MI patients without RA (n = 8070) in a multicentre, nationwide, cohort register study in Finland. The impact of RA duration and the usage of corticosteroids and antirheumatic drugs on RA patients' outcomes were also studied. The median follow-up was 7.3 years. RESULTS: RA was associated with an increased 14-year mortality risk after MI compared with patients without RA [80.4% vs 72.3%; hazard ratio (HR) 1.25; CI: 1.16, 1.35; P <0.0001]. Patients with RA were at higher risk of new MI (HR 1.22; CI: 1.09, 1.36; P =0.0001) and revascularization (HR 1.28; CI: 1.10, 1.49; P =0.002) after discharge from index MI. Cumulative stroke rate after MI did not differ between RA and non-RA patients (P =0.322). RA duration and corticosteroid usage before MI, but not use of methotrexate or biologic antirheumatic drugs, were independently associated with higher mortality (P <0.001) and new MI (P =0.009). A higher dosage of corticosteroids prior to MI was independently associated with higher long-term mortality (P =0.002) and methotrexate usage with lower stroke rate (P =0.034). Serological status of RA was not associated with outcomes. CONCLUSION: RA is independently associated with poorer prognosis after MI. RA duration and corticosteroid usage and dosage were independent predictors of mortality after MI in RA. Special attention is needed for improvement of outcomes after MI in this vulnerable population.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Palomäki A, Kerola AM, Malmberg M, et al. Patients with rheumatoid arthritis have impaired long-term outcomes after myocardial infarction: a nationwide case-control registry study. Rheumatology (Oxford). 2021. PMID: 33667301. doi:10.1093/rheumatology/keab204

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。